Advertisement
Advertisement

INBX

INBX logo

Inhibrx Biosciences, Inc. Common Stock

21.69
USD
-0.23
-1.04%
Aug 01, 16:00 UTC -4
Closed
exchange

After-Market

21.64

-0.05
-0.24%

Inhibrx Biosciences, Inc. Common Stock Profile

Info & Links

CEO

Mark P. Lappe

Headquarters

11025 N. TORREY PINES ROAD, SUITE 140
LA JOLLA, CA 92037, UNITED STATES

Sector

Medical

Auditor

BDO USA, P.C.

Share holders

6

Employees

161

Inhibrx Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

313.26M

Enterprise Value

195.39M

Enterprise Value/EBITDA(ttm)

-0.66

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

452536.51%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

764.15%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

200.00K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

200.00K

EBITDA(ttm)3

-297.92M

Net Income Available to Common(ttm)

1.72B

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

49.50%

S&P 500 52-Week Change

14.53%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

14.48M

Dividend Yield

--

Float4

--

% Held by Insiders

--

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

216.52M

Total Cash Per Share(mrq)

14.96

Total Debt(mrq)

98.65M

Total Debt/Equity(mrq)

104.46%

Current Ratio(mrq)

5.12%

Quick Ratio(mrq)

--

Book Value Per Share(mrq)

6.52

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.32

Free Cash Flow(ytd)

-35.92M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement